Crsp stock forecast 2025.

Forecast . Price target. 89.68 0.00 0.00%. The 22 analysts offering 1 year price forecasts for CRSP have a max estimate of — and a min estimate of —. Analyst rating. Based on 28 analysts giving stock ratings to CRSP in the past 3 months. EPS. Annual Annual Quarterly Quarterly More More

Crsp stock forecast 2025. Things To Know About Crsp stock forecast 2025.

CRSP - CRISPR Therapeutics AG Stock - Stock Price, Institutional Ownership, Shareholders (NASDAQ)Stock Price Forecast. The 7 analysts offering 12-month price forecasts for Corsair Gaming Inc have a median target of 17.00, with a high estimate of 21.00 and a low estimate of 14.00. The median ...NVIDIA Corporation Common Stock. $408.22 -2.95 0.72%. MULN. Mullen Automotive, Inc. Common Stock. $0.116 +0.0059 5.36%. Find the latest analyst research for CRISPR Therapeutics AG Common Shares ...The current CRISPR Therapeutics AG [ CRSP] share price is $66.73. The Score for CRSP is 52, which is 4% above its historic median score of 50, and infers lower risk than normal. CRSP is currently trading in the 50-60% percentile range relative to …

Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52.CRISPR Therapeutics Stock Forecast 30 Nov. Presumably, on 11/30/2023, the price of shares will be in the range of $51.94 - $53.92. A $1.98 range width can provide 3.81% volatility. The weighted average price of this range is at $53.49, which is $0.93 higher than the previous day's weighted average price.

December 2025. Festive spending and end-of-year portfolio adjustments might lead VOO to end on a high note. Predicted Price Range: $450-$470. In the realm of investments, understanding potential trajectories like this can be empowering. Yet, always remember that these are speculative figures.Microsoft Corp Revenue Forecast for 2023 - 2025 - 2030. In the last four years, Microsoft Corp's Revenue has grown by 57.55%, rising from $125.84B to $198.27B. For next year, analysts predict Revenue of $257.87B, which would mean an increase of 30.06%. Over the next seven years, experts predict that Microsoft Corp's Revenue will …

Wall Street Stock Market & Finance report, prediction for the future: You'll find the Rambus share forecasts, stock quote and buy / sell signals below. According to present data Rambus's RMBS shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists).CPRX Stock 12 Months Forecast. $23.30. (81.32% Upside) Based on 5 Wall Street analysts offering 12 month price targets for Catalyst Pharma in the last 3 months. The average price target is $23.30 with a high forecast of $27.00 and a low forecast of $15.50. The average price target represents a 81.32% change from the last price of $12.85.Nov 30, 2023 · CRISPR Therapeutics will start 2025 at $49.04, then soar to $49.76 within the first six months of the year and finish 2025 at $57.16. That means +48% from today. CRISPR Therapeutics Stock Forecast 2030-2034. In this period, the CRISPR Therapeutics price would rise from $82.55 to $103.44, which is +25%. CRSP : CRISPR Therapeutics AG stock forecast, predictions, and share price target for 2022, 2023 (1 year) to 2025 - 2027 (5 year) to 2030, and 2032 (10 year) with Revenue …And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ...

Sep 5, 2023 · And one particular stock to benefit is biotech CRISPR Therapeutics (CRSP 0.92%). The stock has advanced 24% so far this year. And this innovative company could be at the very beginning of its ...

As always, investors should be on the lookout, although it seems unlikely that Facebook or any of the company’s other brands would disappear. Long-term projections have Meta at $272 by the end of 2022 and $360 by the end of 2023. Meta stock will hit $470 in 2025, $580 in 2027, and $765 in 2030, with further gains expected thereafter. …

ARK Invest has a rosy price forecast for Tesla stock and predicts that it rise to $3,000 by 2025. In her best-case scenario, Cathie Wood sees the stock rising 470 percent to $4,000 by 2025. In the ...20 stocks of aerospace and defense companies expected to grow sales most quickly through 2025 Sep. 16, 2023 at 9:07 a.m ...The CRISPR Therapeutics stock price fell by -0.738% on the last day (Friday, 24th Nov 2023) from $70.49 to $69.97. During the last trading day the stock fluctuated 5.38% from a day low at $69.65 to a day high of $73.40. The price has risen in 7 of the last 10 days and is up by 36.5% over the past 2 weeks. Volume fell on the last day along with ...About the Apple, Inc. stock forecast. As of 2023 December 01, Friday current price of AAPL stock is 189.905$ and our data indicates that the asset price has been in an uptrend for the past 1 year (or since its inception).. Apple stock price as been showing a rising tendency so we believe that similar market segments were very popular …CRSP stock extended its rally from levels of around $107 in mid-November 2020 to $161 currently. Also, the stock has rallied a stellar 5x from levels of $34 in late March 2020 – when markets ...Stock Price Forecast. The 8 analysts offering 12-month price forecasts for Caribou Biosciences Inc have a median target of 23.00, with a high estimate of 30.00 and a low estimate of 13.00. The ...

Nov 28, 2023 · Target values for the price of one CRISPR Therapeutics share for Jan 2024. The weighted average target price per CRISPR Therapeutics share in Jan 2024 is: 63.59. In Jan, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.790% volatility is expected. Pessimistic target level: 56.98. About the The Walt Disney Co. stock forecast. As of 2023 December 01, Friday current price of DIS stock is 92.210$ and our data indicates that the asset price has been in a downtrend for the past 1 year (or since its inception).. Walt Disney Co (The) stock price has been showing a declining tendency so we believe that similar market segments …Find real-time UBER - Uber Technologies Inc stock quotes, company profile, news and forecasts from CNN Business.MarketsandMarkets puts the estimate at $11.2 billion by 2025 while Emergen Research estimates the global market size to be $15.79 billion by 2027 or around 17% compounded annual growth rate.NIO's stock forecast in 2025. NIO’s stock forecast for the next 12 months is bullish. According to Tip Ranks, 10 analysts’ median target price for NIO is $65.24, which implies an upside of 44 ...

Find the latest Nouveau Monde Graphite Inc. (NMG) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W ...Oct 27, 2023 · Analyzing the anticipated performance of CRISPR Therapeutics, the ceiling value that the stock is expected to reach in 2025 stands at a promising $75.1.Indicating a bullish trend, an upside potential of 67.9% signals profitable prospects, with an average monthly return of 2.61%, beckoning investors to consider amplifying their portfolios.

SGMO Stock 12 Months Forecast. $2.20. (514.01% Upside) Based on 7 Wall Street analysts offering 12 month price targets for Sangamo Biosciences in the last 3 months. The average price target is $2.20 with a high forecast of $3.00 and a low forecast of $1.00. The average price target represents a 514.01% change from the last price of $0.36.Target values for the price of one CRISPR Therapeutics share for Feb 2026. The weighted average target price per CRISPR Therapeutics share in Feb 2026 is: 39.08. In Feb, the Negative dynamics for Momo shares will prevail with possible monthly volatility of 15.704% volatility is expected. Pessimistic target level: 35.58.KYN Capital Group Inc () Stock Market info Recommendations: Buy or sell KYN Capital Group stock? Wall Street Stock Market & Finance report, prediction for the future: You'll find the KYN Capital Group share forecasts, stock quote and buy / sell signals below.According to present data KYN Capital Group's KYNC shares and potentially its …The average Romeo Power stock forecast 2025 represents a 26.03% increase from the last price of $0.740000009536743. For Romeo Power stock forecast for 2027 (5 year), 12 predictions are offered for each month of 2027 with average Romeo Power stock forecast of $0.94, a high forecast of $0.94, and a low forecast of $0.94. ...CRSP stock has fallen 16% over the last month (twenty-one trading days), after a rise in bond yields, along with rising concerns over the spread of a newer Covid-19 variant - Omicron - led to a ...15 brokers have issued 12-month price objectives for CRISPR Therapeutics' shares. Their CRSP share price targets range from $42.00 to $110.00. On average, they anticipate the company's share price to reach $69.88 in the next year. This suggests a possible upside of 2.9% from the stock's current price.Financial traders can chatter all they want about Apple's earnings miss, but there's data indicating strong upside potential for AAPL stock. A rare earnings miss for Apple doesn't mean you should dump AAPL stock Source: Vytautas Kielaitis /...Teladoc Health Stock Forecast 12-04-2023. Forecast target price for 12-04-2023: $ 18.40. Positive dynamics for Teladoc Health shares will prevail with possible volatility of 2.308%. Pessimistic target level: 18.09. Optimistic target level: 18.52.Casper Sleep Inc. (NYSE:CSPR) announced its quarterly earnings results on Monday, November, 15th. The company reported ($0.61) earnings per share for the quarter, missing the consensus estimate of ($0.43) by $0.18. The company had revenue of $156.50 million for the quarter, compared to analyst estimates of $156.15 million.

Editas Medicine (EDIT) stock price prediction is 21.770642845038 USD. The Editas Medicine stock forecast is 21.770642845038 USD for 2024 November 30, Saturday; and 92.327 USD for 2028 November 30, Thursday with technical analysis.

CRSP stock has fallen 16% over the last month (twenty-one trading days), after a rise in bond yields, along with rising concerns over the spread of a newer Covid-19 variant - Omicron - led to a ...

The news had a broad impact on gene-editing stocks including CRSP stock, which fell almost 3%. But analysts aren't by and large concerned. William Blair analysts rate CRSP stock with an outperform ...32.69%. Dividend Yield. N/A. More importantly, CRISPR Therapeutics' financial results should improve in the next five years. The company is on the verge of receiving approval for exa-cel, a gene ...Nov 28, 2023 · CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 21, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics AG (CRSP) now CRISPR Therapeutics AG 69.97 D 0.74% (0.52) What analysts predict: $87.78 52-week High/Low: $76.19 / $37.55 50/200 Day Moving Average: $46.64 / $51.55 Target values for the price of one Clover Health Investments share for Nov 2025. The weighted average target price per Clover Health Investments share in Nov 2025 is: 2.33. In Nov, the Positive dynamics for Momo shares will prevail with possible monthly volatility of 22.238% volatility is expected. Pessimistic target level: 2.00.Butterfly Network Inc - Class A Stock Forecast, BFLY stock price prediction. Price target in 14 days: 1.290 USD. ... Class A Stock Price Forecast for 2025: January ...Find real-time VTRS - Viatris Inc stock quotes, company profile, news and forecasts from CNN Business.Price target in 14 days: 89.877 USD. The best long-term & short-term CRISPR Therapeutics AG share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily CRSP …For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.Jun 6, 2021 · For Editas Medicine stock forecast for 2031, 12 predictions are offered for each month of 2031 with average Editas Medicine stock forecast of $8.2, a high forecast of $8.21, and a low forecast of $8.19. The average Editas Medicine stock forecast 2031 represents a 4.21% increase from the last price of $7.86999988555908.

Apr 14, 2022 · The first chart below shows the global market size of CRISPR gene editing in 2019 and a forecast for 2030. The market is set to increase by a mind-boggling 1,179% to reach more than $10 billion by ... NIO's stock forecast in 2025. NIO’s stock forecast for the next 12 months is bullish. According to Tip Ranks, 10 analysts’ median target price for NIO is $65.24, which implies an upside of 44 ...CRISPR Therapeutics (CRSP) stock forecast for 2025 Last update: November 28, 2023 (07:48) Sector: Healthcare The share price of CRISPR Therapeutics …Instagram:https://instagram. dow jones index etfodds traderpgboxhow much is ambetter insurance a month Stock Price Forecast. The 5 analysts offering 12-month price forecasts for Danimer Scientific Inc have a median target of 3.00, with a high estimate of 3.75 and a low estimate of 2.00. The median ... workers compensation carriers in floridamullens stock The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price. napa auto zone The Upstart Holdings stock prediction for 2025 is currently $ 64.08, assuming that Upstart Holdings shares will continue growing at the average yearly rate as they did in the last 10 years. This would represent a 141.45% increase in the UPST stock price. According to Wall Street's consensus estimates, these four stocks are forecast to increase sales by 25,750% to as much as 2,970,000% (that's nearly 3 million percent) over the next five years.